Literature DB >> 17903220

Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells.

A Windhagen1, D Sönmez, H T Hornig-Do, A Kalinowsky, R Schwinzer.   

Abstract

The C77G polymorphism in exon A of the human CD45 gene occurs with low frequency in healthy individuals. An enhanced frequency of C77G individuals has been reported in cohorts of patients suffering from multiple sclerosis, systemic sclerosis, autoimmune hepatitis, hepatitis C and human immunodeficiency virus (HIV)-1. C77G individuals overexpress CD45RA isoforms on activated/memory T cells. We have shown previously that aberrant expression of CD45RA isoforms enhances the intensity of T cell receptor (TCR) signalling. Here we report that the C77G polymorphism also influences the responsiveness of T cells to cytokines and alters their adhesion properties. When stimulated by interleukin (IL)-2, C77G T cells proliferated more strongly than wild-type controls and showed accelerated phosphorylation of Janus kinase (Jak1). Furthermore, C77G T cells exhibited a higher tendency to form homotypic aggregates in culture which could be enhanced significantly by antibody-mediated triggering of the variant CD45RA molecules. These data indicate that the changes in CD45 isoform combination resulting from C77G may not only affect TCR signalling but also cytokine-driven T cell responses and cellular adhesion. Altered immune responsiveness may enhance susceptibility of C77G carriers for certain diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17903220      PMCID: PMC2219380          DOI: 10.1111/j.1365-2249.2007.03508.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45.

Authors:  H Shenoi; J Seavitt; A Zheleznyak; M L Thomas; E J Brown
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

Review 2.  CD45: a critical regulator of signaling thresholds in immune cells.

Authors:  Michelle L Hermiston; Zheng Xu; Arthur Weiss
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  Functional significance of the 77C --> G polymorphism in the human CD45 gene: enhanced T-cell reactivity by variantly expressed CD45RA isoforms.

Authors:  H-T Do; W Baars; R Schwinzer
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

4.  A point mutation in PTPRC is associated with the development of multiple sclerosis.

Authors:  M Jacobsen; D Schweer; A Ziegler; R Gaber; S Schock; R Schwinzer; K Wonigeit; R B Lindert; O Kantarci; J Schaefer-Klein; H I Schipper; W H Oertel; F Heidenreich; B G Weinshenker; N Sommer; B Hemmer
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

5.  PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.

Authors:  L F Barcellos; S Caillier; L Dragone; M Elder; E Vittinghoff; P Bucher; R R Lincoln; M Pericak-Vance; J L Haines; A Weiss; S L Hauser; J R Oksenberg
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

6.  Protein tyrosine phosphatase receptor-type C exon 4 gene mutation distribution in an Italian multiple sclerosis population.

Authors:  Clara Ballerini; Eleonora Rosati; Marco Salvetti; Giovanni Ristori; Stefania Cannoni; Tiziana Biagioli; Luca Massacesi; Sandro Sorbi; Marco Vergelli
Journal:  Neurosci Lett       Date:  2002-08-16       Impact factor: 3.046

7.  CD45 mAb induces cell adhesion in peripheral blood mononuclear cells via lymphocyte function-associated antigen-1 (LFA-1) and intercellular cell adhesion molecule 1 (ICAM-1).

Authors:  H M Lorenz; T Harrer; A S Lagoo; A Baur; G Eger; J R Kalden
Journal:  Cell Immunol       Date:  1993-03       Impact factor: 4.868

8.  A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population.

Authors:  H Thude; S Rosenhahn; W Hunger-Dathe; U-A Müller; D Barz
Journal:  Eur J Immunogenet       Date:  2004-12

9.  Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.

Authors:  M Streuli; L R Hall; Y Saga; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis.

Authors:  Sally Boxall; James McCormick; Peter Beverley; Stephan Strobel; Paola De Filippi; Ritu Dawes; Catherine Klersy; Rita Clementi; Emanuella De Juli; Aline Ferster; Diana Wallace; Maurizio Aricò; Cezare Danesino; Elma Tchilian
Journal:  Pediatr Res       Date:  2003-11-19       Impact factor: 3.756

View more
  8 in total

1.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

2.  Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis.

Authors:  Shuzhong Zhang; Mingquan Zheng; Ryoko Kibe; Yunping Huang; Luis Marrero; Samantha Warren; Arthur W Zieske; Tomoo Iwakuma; Jay K Kolls; Yan Cui
Journal:  FASEB J       Date:  2011-04-06       Impact factor: 5.191

Review 3.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

4.  N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death.

Authors:  Lesley A Earl; Shuguang Bi; Linda G Baum
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

5.  The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells.

Authors:  Ildar Gabaev; Lars Steinbrück; Claudia Pokoyski; Andreas Pich; Richard J Stanton; Reinhard Schwinzer; Thomas F Schulz; Roland Jacobs; Martin Messerle; Penelope C Kay-Fedorov
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

6.  C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease.

Authors:  Johannes Landskron; Sigrid M Kraggerud; Elisabeth Wik; Anne Dørum; Merete Bjørnslett; Espen Melum; Øystein Helland; Line Bjørge; Ragnhild A Lothe; Helga B Salvesen; Kjetil Taskén
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

Review 7.  Alternative Splicing of Pre-mRNA in the Control of Immune Activity.

Authors:  Zhongjing Su; Dongyang Huang
Journal:  Genes (Basel)       Date:  2021-04-15       Impact factor: 4.096

8.  Natural Antisense Transcript PEBP1P3 Regulates the RNA Expression, DNA Methylation and Histone Modification of CD45 Gene.

Authors:  Zhongjing Su; Guangyu Liu; Bin Zhang; Ze Lin; Dongyang Huang
Journal:  Genes (Basel)       Date:  2021-05-17       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.